February 2026 Deadline — 50% Calecim

Calecim based in Singapore, owns 100%. In addition to cosmeceuticals, they hopes to use Cord Lining Stem Cell Technology in other medical specialties to address unmet medical needs and support the world's healthcare systems. Calecim after in-clinic procedures, skin is immediately calmed, soothed, and restored with a light serum made with high concentrations of Rejuvenating Conditioned Media. Results are felt and perceptible right away, and with continued use, long-term aesthetic benefits become apparent. With high concentrations of functional stem cell proteins, Professional Serum accelerates their skin's natural healing process. The aesthetic doctor's choice of clinical skincare as it dramatically improves treatment results, and delivers visibly firmed and lifted skin.